FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012081062> ?p ?o ?g. }

• W2012081062 endingPage "1466" @default.
• W2012081062 startingPage "1458" @default.
• W2012081062 abstract "To determine the benefit of genistein combined polysaccharide (GCP) in combination with the androgen receptor antagonist bicalutamide, the antimicrotubule taxane docetaxel, and the Src kinase inhibitor pp2 as part of a treatment regimen for advanced prostate cancer (CaP).The growth inhibitory and apoptotic effects of GCP in combination with bicalutamide, docetaxel and pp2 were evaluated in both the androgen-dependent LNCaP line, and three androgen-independent lines: CWR22Rv1, PC-3, and LNCaP-R273H. The LNCaP-R273H model is an LNCaP variant expressing a p53(GOF) allele; like CWR22Rv1 and PC-3, it is able to grow in a minimal androgen environment. The effects of GCP treatment in combination with the aforementioned drugs were measured using an MTT assay, Western blotting, flow cytometric analysis, and caspase activation assay. Altered schedules of drug administration were explored using combinations of GCP and docetaxel.GCP potentiated the activity of docetaxel in all four cell lines, resulting in growth inhibition and increased apoptosis. The combination of GCP and bicalutamide had enhanced activity in both the LNCaP and LNCaP-R273H lines, which may better represent patient tumour cells after progression to androgen independence. Administration of docetaxel followed by GCP resulted in a synergistic interaction in LNCaP cells, with increased apoptosis. By contrast, GCP administered first showed subadditivity, probably resulting from GCP-mediated induction of G1 arrest interfering with docetaxel activity.These data suggest that GCP, an isoflavone-enriched compound with minimal side-effects and far superior intestinal absorption rate of genistein, has significant clinical potential in combination with docetaxel, bicalutamide or targeted agents for the treatment of advanced CaP." @default.
• W2012081062 created "2016-06-24" @default.
• W2012081062 creator A5000966901 @default.
• W2012081062 creator A5010265482 @default.
• W2012081062 creator A5013458022 @default.
• W2012081062 creator A5018205931 @default.
• W2012081062 creator A5038194485 @default.
• W2012081062 creator A5048911513 @default.
• W2012081062 date "2008-10-23" @default.
• W2012081062 modified "2023-10-16" @default.
• W2012081062 title "Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines" @default.
• W2012081062 cites W1493421451 @default.
• W2012081062 cites W1883178470 @default.
• W2012081062 cites W1888905687 @default.
• W2012081062 cites W1903014736 @default.
• W2012081062 cites W1975413544 @default.
• W2012081062 cites W1975444842 @default.
• W2012081062 cites W1989656600 @default.
• W2012081062 cites W1990301115 @default.
• W2012081062 cites W1994182197 @default.
• W2012081062 cites W1999642875 @default.
• W2012081062 cites W1999760670 @default.
• W2012081062 cites W2001333573 @default.
• W2012081062 cites W2010302075 @default.
• W2012081062 cites W2014189549 @default.
• W2012081062 cites W2016001610 @default.
• W2012081062 cites W2022301159 @default.
• W2012081062 cites W2027244560 @default.
• W2012081062 cites W2028657420 @default.
• W2012081062 cites W2050948499 @default.
• W2012081062 cites W2052291941 @default.
• W2012081062 cites W2057184021 @default.
• W2012081062 cites W2060353656 @default.
• W2012081062 cites W2071946615 @default.
• W2012081062 cites W2075884509 @default.
• W2012081062 cites W2077945404 @default.
• W2012081062 cites W2080439368 @default.
• W2012081062 cites W2084877604 @default.
• W2012081062 cites W2087922043 @default.
• W2012081062 cites W2089091539 @default.
• W2012081062 cites W2089221370 @default.
• W2012081062 cites W2099560338 @default.
• W2012081062 cites W2106599502 @default.
• W2012081062 cites W2109454972 @default.
• W2012081062 cites W2136380173 @default.
• W2012081062 cites W2142284564 @default.
• W2012081062 cites W2146275677 @default.
• W2012081062 cites W2147633287 @default.
• W2012081062 cites W2150775704 @default.
• W2012081062 cites W2159351478 @default.
• W2012081062 cites W2161703012 @default.
• W2012081062 cites W2161938729 @default.
• W2012081062 cites W2163113427 @default.
• W2012081062 cites W2169618540 @default.
• W2012081062 doi "https://doi.org/10.1111/j.1464-410x.2008.07826.x" @default.
• W2012081062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18565171" @default.
• W2012081062 hasPublicationYear "2008" @default.
• W2012081062 type Work @default.
• W2012081062 sameAs 2012081062 @default.
• W2012081062 citedByCount "8" @default.
• W2012081062 countsByYear W20120810622012 @default.
• W2012081062 countsByYear W20120810622018 @default.
• W2012081062 countsByYear W20120810622020 @default.
• W2012081062 crossrefType "journal-article" @default.
• W2012081062 hasAuthorship W2012081062A5000966901 @default.
• W2012081062 hasAuthorship W2012081062A5010265482 @default.
• W2012081062 hasAuthorship W2012081062A5013458022 @default.
• W2012081062 hasAuthorship W2012081062A5018205931 @default.
• W2012081062 hasAuthorship W2012081062A5038194485 @default.
• W2012081062 hasAuthorship W2012081062A5048911513 @default.
• W2012081062 hasConcept C121608353 @default.
• W2012081062 hasConcept C126322002 @default.
• W2012081062 hasConcept C134018914 @default.
• W2012081062 hasConcept C143998085 @default.
• W2012081062 hasConcept C2779723316 @default.
• W2012081062 hasConcept C2780192828 @default.
• W2012081062 hasConcept C2780962315 @default.
• W2012081062 hasConcept C2781190966 @default.
• W2012081062 hasConcept C502942594 @default.
• W2012081062 hasConcept C61367390 @default.
• W2012081062 hasConcept C71924100 @default.
• W2012081062 hasConcept C98274493 @default.
• W2012081062 hasConceptScore W2012081062C121608353 @default.
• W2012081062 hasConceptScore W2012081062C126322002 @default.
• W2012081062 hasConceptScore W2012081062C134018914 @default.
• W2012081062 hasConceptScore W2012081062C143998085 @default.
• W2012081062 hasConceptScore W2012081062C2779723316 @default.
• W2012081062 hasConceptScore W2012081062C2780192828 @default.
• W2012081062 hasConceptScore W2012081062C2780962315 @default.
• W2012081062 hasConceptScore W2012081062C2781190966 @default.
• W2012081062 hasConceptScore W2012081062C502942594 @default.
• W2012081062 hasConceptScore W2012081062C61367390 @default.
• W2012081062 hasConceptScore W2012081062C71924100 @default.
• W2012081062 hasConceptScore W2012081062C98274493 @default.
• W2012081062 hasIssue "10" @default.
• W2012081062 hasLocation W20120810621 @default.
• W2012081062 hasLocation W20120810622 @default.
• W2012081062 hasOpenAccess W2012081062 @default.

• next